This week in Other Barks & Bites: The Federal Circuit issues several precedential decisions, including one reviving the patent claims in VirnetX and another determining that America Invents Act (AIA) validity trials don’t violate the Fifth Amendment’s Takings Clause in Celgene. This week in Other Barks & Bites: The Federal Circuit issues several precedential decisions, including one reviving the patent claims in VirnetX and another determining that America Invents Act (AIA) validity trials don’t violate the Fifth Amendment’s Takings Clause in Celgene; the USPTO proposes fee increases to patent examination and AIA trials and issues a final rule on e-filing in trademark registrations; Katy Perry is ordered to pay $2.7 million for copyright infringement; free OTA TV service Locast is targeted in a copyright suit filed by Disney and other major broadcasters; Pfizer and Mylan consider creating a global giant in off-patent drugs; the University of California files patent suits against major retailers over LED light bulb technology; and patent applications listing artificial intelligence machine inventor are filed in patent offices across the world.
Other Barks & Bites, July 26: VirnetX Patent Claims Revived, AIA Trial Fees Increased, and CAFC Rules in Celgene that AIA Trials Do Not Violate the Fifth Amendment
No Comments
Business
- The USPTO Wants a Rehearing in Arthrex: Now is the Time to Put the PTAB on Trial
- One Inventor’s Unsolicited Congressional Testimony Following Arthrex
- How to Prepare and Prosecute Patents in Light of the USPTO’s Post-Alice Focus on Eligibility
- Other Barks & Bites for Friday, November 29: China Pledges ‘Social Satisfaction’ on IP Protection and Nominates Candidate to Head WIPO
- Don’t Undermine U.S. Innovation While Standing Up to China
Recent Posts
- Another Front in China’s Economic War: Senate IP Subcommittee Seeks to Solve USPTO’s Fraudulent Chinese Trademarks Problem
- The USPTO Wants a Rehearing in Arthrex: Now is the Time to Put the PTAB on Trial
- One Inventor’s Unsolicited Congressional Testimony Following Arthrex
- How to Prepare and Prosecute Patents in Light of the USPTO’s Post-Alice Focus on Eligibility
- The Top Five Most Memorable Insurance Company Brand Personalities